[ASAP] Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects < subtitle > Miniperspective < /subtitle >

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.8b01531

Source: Journal of Medicinal Chemistry - November 16, 2018 Category: Chemistry Authors: Xiaoyun Lu, Hao Chen, Adam V. Patterson, Jeff B. Smaill, Ke Ding Source Type: research